Idera Pharmaceuticals, Inc. Announces 2006 Financial Results For The Three And Six Months Ended June 30, 2006; Recent Highlights Include Expanded TLR Programs And Additional Funding

Idera Pharmaceuticals Inc. (AMEX: IDP), a biopharmaceutical company focused on developing therapeutics targeting Toll-like Receptors (TLRs), today reported financial results for the three and six months ended June 30, 2006.

MORE ON THIS TOPIC